- UCB has selected Gwinnett County, Georgia, for a new 460,000 sq. ft. biologics manufacturing facility designed with AI, robotics, and automation.
- The project is expected to generate approximately $5 billion in economic impact and create around 330 permanent jobs and over 1,000 construction roles.
UCB has selected Gwinnett County, Georgia, as the location for a new biologics manufacturing facility as part of its ongoing U.S. expansion strategy. The company said the campus will use a digital-first approach, incorporating artificial intelligence, robotics, and automation, while focusing on efficient use of natural resources. The facility will be built within the Rowen development in the Atlanta metropolitan area, where UCB has maintained its U.S. headquarters for more than three decades.
The site will span approximately 460,000 square feet across 79 acres and is intended to support continuous, 24/7 production of complex biologics primarily for the U.S. market. According to the company, the facility will integrate into its global manufacturing network to strengthen supply resilience and support demand for its existing biologics portfolio and pipeline. The campus will also serve as a hub for U.S. manufacturing operations.
The investment aligns with UCB’s long-term growth strategy, which includes continued investment in innovation and manufacturing capacity. The company reported 15 FDA approvals or indication expansions, including nine in the past three years. The new facility is intended to support commercial production of recently approved medicines as well as future pipeline products, reinforcing the company’s presence across research, development, and manufacturing in the U.S.
“This decision reflects our confidence in UCB’s long-term growth and our deep-rooted commitment to the United States. By investing in Gwinnett County and the Rowen Foundation in Georgia, where our U.S. headquarters have been based for more than three decades, we are strengthening our biologics manufacturing capabilities, supporting our innovation pipeline, and creating high-quality jobs in a state that offers outstanding talent, a strong manufacturing tradition, and an ecosystem designed for sustainable, long-term success.”
Jean-Christophe Tellier, CEO of UCB
The project is expected to generate approximately $5 billion in total economic impact. UCB said the development will create around 330 permanent roles and more than 1,000 construction jobs. The Rowen site was selected for its infrastructure, permitting processes, and proximity to academic institutions including Georgia Tech and the University of Georgia, which provide access to talent in science, engineering, and advanced manufacturing.
